Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Zomedica ( (ZOMDF) ) has provided an update.
Zomedica reported a 14% increase in revenue for the second quarter of 2025, reaching $7 million, with a gross margin of 67%. The company achieved record year-over-year revenue growth for the 18th consecutive quarter, driven by strong performance in its diagnostic and therapeutic segments. The TRUFORMA diagnostic platform saw an 86% growth in revenue, while consumable sales increased by 21%. Zomedica’s strategic initiatives, including the launch of an Equine Asthma registry and enhancements to existing products, are expected to support future recurring sales. The company is well-positioned to continue its global expansion and drive accelerated adoption of its innovative product portfolio.
The most recent analyst rating on (ZOMDF) stock is a Buy with a $0.25 price target. To see the full list of analyst forecasts on Zomedica stock, see the ZOMDF Stock Forecast page.
Spark’s Take on ZOMDF Stock
According to Spark, TipRanks’ AI Analyst, ZOMDF is a Neutral.
Zomedica’s stock score reflects mixed financial performance with revenue growth but persistent profitability challenges. The technical analysis shows weak momentum, and the valuation is impacted by a negative P/E ratio. Despite strong earnings call highlights, increased net loss and delisting risks present concerns.
To see Spark’s full report on ZOMDF stock, click here.
More about Zomedica
Zomedica is a veterinary health company that provides point-of-care diagnostic and therapeutic products for equine and companion animals. Their primary products include the PulseVet and Assisi therapeutic devices, as well as the TRUFORMA diagnostic platform. The company focuses on expanding its product portfolio and optimizing its commercial operations to drive growth and adoption in the veterinary market.
Average Trading Volume: 1,316,205
Technical Sentiment Signal: Sell
Current Market Cap: $37.68M
For an in-depth examination of ZOMDF stock, go to TipRanks’ Overview page.